← Back to patent-cliff list
CAS 317374-07-5
N-(4-bromo-3-methylphenyl)-2-methylbenzamide
Codes: TOLV-018
Application context (from source-drug indications)
Autosomal dominant polycystic kidney diseaseTolvaptanFibrosisTolvaptanHyponatraemiaTolvaptanHeart failureTolvaptanSyndrome of inappropriate antidiuretic hormone secretionTolvaptan
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tolvaptan | Tier B — Position early | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
7-chloro-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one→N-(4-(7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide→N-(4-bromo-3-methylphenyl)-2-methylbenzamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.